Results 231 to 240 of about 843,078 (353)

Identification of Actionable Gene Variants in Pulmonary Large-Cell Neuroendocrine Carcinoma: A Real-World Analysis of a Polish Cohort. [PDF]

Int J Mol Sci
Szpechcinski A, Pelc M, Lechowicz U, Szolkowska M, Moes-Sosnowska J, Rudzinski P, Wojda E, Skronska P, Podgorska E, Maszkowska-Kopij K, Polaczek M, Orlowski T, Langfort R, Chorostowska-Wynimko J.   +13 more
europepmc   +1 more source

Metastatic Lung Non-Small Cell Carcinoma [PDF]

, 2020
openaire   +1 more source

Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition.

Cancer Research, 2005
S. Thomson, E. Buck, F. Petti, Graeme Griffin, E. Brown, Nishal Ramnarine, K. Iwata, N. Gibson, J. Haley   +8 more
semanticscholar   +1 more source

Selective Targeting of Immune Checkpoints HLA‐G and CD47 Using Novel Dual Signaling Protein DSP216 Promotes Innate Anticancer Immunity

Advanced Science, EarlyView.
The inhibitory immune checkpoints HLA‐G and CD47 are expressed on certain tumor types and inhibit immune cells in the tumor microenvironment. DSP216 binds specifically to cancer cells expressing both HLA‐G and CD47, and blocks their inhibitory signaling.
Lisa J. Jacob, Liat Tamir, Mufeed Abdeen, Ami Tamir, Alexandra Aronin, Itai Bloch, Roy Kahn, Iris Pecker, Mark Tykocinski, Gerwin Huls, Yaron Pereg, Ayelet Chajut, Edwin Bremer   +12 more
wiley   +1 more source

Minimal invasive treatment for peripheral non small cell lung carcinoma

Chinese Journal of Lung Cancer, 2008
Hongwu WANG
doaj  

Lung cancer treatment pathways in the largest private health insurance in Brazil: a real-world data study. [PDF]

BMC Cancer
da Silva Sardenberg RA, de Campos CAL, Porto BC, da Cruz JAS.   +3 more
europepmc   +1 more source

Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin.

The Lancet Oncology, 2015
Matthew G. Oser, M. Niederst, L. Sequist, J. Engelman   +3 more
semanticscholar   +1 more source

NSUN5 Attenuates Renal Injury and Ferroptosis in Hyperuricaemic Nephropathy Through YBX2‐Dependent Stabilisation of SCD1 m5C Methylation

Advanced Science, EarlyView.
NSUN5 is downregulated in hyperuricaemic nephropathy. Overexpression of NSUN5 enhances the stability of SCD1 mRNA through the m5C reader YBX2, ultimately inhibiting ferroptosis in renal tubular epithelial cells. Additionally, this axis suppresses the NF‐κB signaling pathway to alleviate inflammation and upregulates ABCG2 to promote uric acid excretion,
Xiu‐xiu Song, Xiao‐guo Suo, Yue Yu, Kuo Zhang, Chen‐ao Li, Jie Wang, Hui‐xia Xu, Si‐yu Niu, Dong‐xue Lv, Zi‐hao He, Feng‐he Li, Xiao‐ming Meng, Juan Jin   +12 more
wiley   +1 more source

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

Journal of Clinical Oncology, 2004
D. Pfister, David H. Johnson, C. Azzoli, W. Sause, Thomas J. Smith, Sherman Baker, J. Olak, D. Stover, John R. Strawn, A. Turrisi, M. Somerfield   +10 more
semanticscholar   +1 more source

In Vivo CRISPR Screening Identifies the Glutamate Receptor GRIA2 as Promoting Peritoneal Metastasis of Gastric Cancer via Calcium‐Dependent β‐Catenin Activation

Advanced Science, EarlyView.
We identified GRIA2 as a critical driver of gastric cancer peritoneal metastasis through in vivo CRISPR screening. Mechanistically, GRIA2‐mediated calcium influx inhibits GSK3β and activates Wnt/β‐catenin signaling, driven by glutamate from cancer‐associated fibroblasts.
Jie Sun, Xu Yang, Wenchao Jiang, Chengbo Ji, Yingying Wu, Haoyu Sun, Xinyou Liu, Masami Yamamoto, Tetsuya Tsukamoto, Sachiyo Nomura, Junjie Zhao, Yuanyuan Ruan, Haojie Li, Xuefei Wang   +13 more
wiley   +1 more source